Diabetes and tuberculosis: a syndemic difficult by COVID-19


This article was originally published here

Med Clin (Barc). 2021, May 6: S0025-7753 (21) 00208-6. doi: 10.1016 / j.medcli.2021.04.004. Online before printing.


Tuberculosis (TB) is the leading cause of infectious mortality worldwide and primarily affects developing countries (DC), while diabetes (DM) is one of the most common chronic diseases. This review analyzes the fact that diabetes is currently a major risk factor for developing tuberculosis and also has more complicated tuberculosis, more relapses, and higher mortality. The DCs and fourth world of major cities are the ones with the highest incidence of TB and an increase in DM, making tuberculosis disease difficult to control. At the same time, the COVID-19 pandemic is making both diseases difficult to treat due to the difficulty of accessing control and treatment and the worsening of socio-economic inequalities. There is a need to establish bidirectional screening for TB and DM and promote recommendations for treating both diseases together.

PMID: 34049681 | DOI: 10.1016 / j.medcli.2021.04.004